Form 8-K - Current report:
SEC Accession No. 0001493152-25-000271
Filing Date
2025-01-03
Accepted
2025-01-03 16:35:42
Documents
15
Period of Report
2025-01-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44549
2 ex99-1.htm EX-99.1 9059
3 ex99-2.htm EX-99.2 22816
  Complete submission text file 0001493152-25-000271.txt   253367

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vbiv-20250103.xsd EX-101.SCH 3024
5 XBRL LABEL FILE vbiv-20250103_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vbiv-20250103_pre.xml EX-101.PRE 24171
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3222
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 25507014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)